Mosaico study

The world can still end AIDS by 2030

Summary: UNAIDS, an organization that works to end AIDS, says that even though a recent trial for an HIV vaccine did not work, it is important to continue using other ways to prevent and treat HIV. They say that by using existing methods and making them more widely available, we can still reach the goal of ending AIDS by 2030. The trial was stopped because it did not show that the vaccine was effective. The Joint United Nations Programme on HIV/AIDS

Major setback for HIV vaccine research

Janssen Pharmaceutical Companies of Johnson & Johnson, together with a consortium of global partners, have announced that an independent data review of the Phase 3 Mosaico study of Janssen’s investigational HIV vaccine regimen was not effective in preventing HIV infection among the study participants. The study will be discontinued and further analysis of the data will be conducted. They revealed no safety issues with the vaccine regimen were identified during the trial. The consortium of global partners